 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: GS-6615 | GS6615
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Eleclazine is a sodium channel inhibitor, modulating cardiac late Na+ currents via the Nav1.5 (gene symbol SCN5A) channel. The compound is a dihydrobenzodiazepine type structure. Dihydrobenzodiazepine scaffolds are being developed as α-helix mimetics, with the potential to inhibit protein-protein interactions [1,3-5]. This chemical structure and its use is covered by patent US20150038489 [2].
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Classification  | |
| Compound class | Synthetic organic | 
| IUPAC Name  | 
| 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 9978 | eleclazine | 
| Synonyms  | 
| GS-6615 | GS6615 | 
| Database Links  | |
| CAS Registry No. | 1443211-72-0 | 
| GtoPdb PubChem SID | 252166623 | 
| PubChem CID | 71183216 | 
| Search Google for chemical match using the InChIKey | YNUAEEJQYHYLMS-UHFFFAOYSA-N | 
| Search Google for chemicals with the same backbone | YNUAEEJQYHYLMS | 
| Search PubMed clinical trials | eleclazine | 
| Search PubMed titles | eleclazine | 
| Search PubMed titles/abstracts | eleclazine | 
| UniChem Compound Search for chemical match using the InChIKey | YNUAEEJQYHYLMS-UHFFFAOYSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | YNUAEEJQYHYLMS-UHFFFAOYSA-N |